Vaccine effectiveness to protect against moderate or severe disease in COVID cases: A prospective cohort study

Rajneesh K. Joshi, C.G. Muralidharan,Ankur Ahuja,Reema Mukherjee, Sachin Chaurasia, Linto Manjaly, Divyanshi,A.K. Sahoo,Jayesh Gosavi, Alok Thomas

Medical journal, Armed Forces India（2023）

引用 1|浏览6

暂无评分

摘要

Interval between the first and second doses of ChAdOx1 nCoV-19 vaccine should be reduced to 4-6 weeks, as partial vaccination offers lower protection against the development of moderate-severe illness after COVID infection.

查看译文

关键词

COVID,Vaccine effectiveness,Covishield,ChAdOx1 nCoV-19 vaccine

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要